Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.

Author: KennyAnne M, KleppingerAlison, KulldorffMartin, PrestwoodKaren M

Paper Details 
Original Abstract of the Article :
CONTEXT: Estrogen therapy is known to prevent osteoporosis, but studies have shown that conventional doses increase adverse events. Whether lower doses, one quarter of standard treatment, prevent bone loss is not known. OBJECTIVE: To examine the effect of 3 years of treatment with 0.25 mg/d of micr...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/12941676

データ提供:米国国立医学図書館(NLM)

Low-Dose Estrogen Therapy for Bone Health in Older Women

Estrogen therapy is well-known for its role in preventing osteoporosis, but concerns about potential side effects have led to investigations into lower-dose alternatives. This randomized controlled trial explores the impact of a low-dose (0.25 mg/d) of micronized 17beta-estradiol on bone mineral density (BMD) and bone turnover in healthy older postmenopausal women.

Low-Dose Estrogen Therapy: A Bone-Building Strategy for Older Women

The study found that low-dose estrogen therapy significantly increased BMD at all sites (hip, spine, wrist, and total body) in older women compared to placebo. This finding suggests that even at lower doses, estrogen can effectively promote bone health in older women, mitigating the risk of osteoporosis. Furthermore, markers of bone turnover, indicating bone resorption and formation, were significantly reduced in the estrogen-treated group, demonstrating a positive impact on bone metabolism.

A Balanced Approach to Estrogen Therapy

This research provides strong evidence for the efficacy of low-dose estrogen therapy in improving bone health in older women. While further research is needed to fully understand its long-term effects and potential risks, this study offers a promising approach to managing bone health in this age group.

Dr.Camel's Conclusion

This study is like a refreshing oasis in the desert, offering a safe and effective alternative to traditional high-dose estrogen therapy. Low-dose estrogen therapy holds the potential to improve bone health in older women while minimizing potential side effects.

Date :
  1. Date Completed 2003-09-02
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

12941676

DOI: Digital Object Identifier

290/8/1042

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.